Dual effect of nitric oxide donor on adjuvant arthritis

International Immunopharmacology

Volumn 9, Issue 4, 2009, Pages 439-447

  Gomaa, Adel A ^a   Elshenawy, Mohsen M ^a   Afifi, Noha A ^a   Mohammed, Eman A ^b   Thabit, Romany H ^a  

^a Assiut University Faculty of Medicine   (Egypt)

^b Assiut University   (Egypt)

Author keywords

Adjuvant arthritis; Dose; Dual; NO

Indexed keywords

INTERLEUKIN 10; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE EDEMA; ARTICLE; BODY TEMPERATURE; BODY WEIGHT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HISTOPATHOLOGY; HYPERALGESIA; NONHUMAN; PAIN THRESHOLD; PAW EDEMA; PRIORITY JOURNAL; PROPHYLAXIS; RAT;

ANIMALS; ANKLE JOINT; ARTHRITIS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; FEMALE; FREUND'S ADJUVANT; INTERLEUKIN-10; NITRIC OXIDE DONORS; NITROPRUSSIDE; RATS; RATS, SPRAGUE-DAWLEY; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 61649126204     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.01.009     Document Type: Article

References (56)

1. Wallberg-Jonsson S., Ohman M.L., and Dahlqvist S.R. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in northern Sweden. J Rheumatol 24 (1997) 445-451
2. Lane N.E., Williams E.N., Hung Y.Y., H ochberg M.C., Cummings S.R., and Nevitt M.C. Association of nitrate use with risk of new radiographic features of hip osteoarthritis in elderly white women: the study of osteoporotic fractures. Arthritis Rheum 49 (2003) 752-758
3. Jacob T., Morrell M., Manzi S., Verdile V., Simmons R.L., and Peitzman A. Elevated nitrites in inflammatory joint disease: nitric oxide in the arthritides. Arthritis Rheum 35 (1992) R9-15
4. Yki-Jarvinen H., Bergholm R., and Leirisalo-Repo M. Increased inflammatory activity parallels increased basal nitric oxide production and blunted response to nitric oxide in vivo in rheumatoid arthritis. Ann Rheum Dis 62 (2003) 630-634
5. Scher J.U., Pillinger M.H., and Abramson S.B. Nitric oxide synthases and osteoarthritis. Curr Rheum Reports 9 (2007) 9-15
6. Vuolteenaho K., Moilanen T., Knowles R.G., and Moilanen E. The role of nitric oxide in osteoarthritis. Scand J Rheumatol 36 (2007) 247-258
7. Fermor B., Christensen S.E., Youn I., Cernancec J.M., Davies C.M., and Weinberg J.B. Oxygen, nitric oxide and articular cartilage. Eur cells Mterials 13 (2007) 56-65
8. Nagy G., Clark J.M., Buzas E., Gorman C., Pasztoi M., Koncz A., et al. Nitric oxide production of T lymphocytes is increased in rheumatoid arthritis. Immunol Lett 118 (2008) 55-58
9. Nagy G., Clark J.M., Buzas E.I., Gorman C.L., and Cope A.P. Nitric oxide, chronic inflammation and autoimmunity. Immunol Lett 111 (2007) 1-5
10. Migita K., Yamasaki S., Kita M., Ida H., and Shibatomi K. Nitric oxide protects cultured rheumatoid synovial cells from Fas-induced apoptosis by inhibiting caspase-3. Immunology 103 (2001) 362-367
11. Paul-Clark M.J., Gilory D.W., Willis D., Willoughby D.A., and Tomlinson A. Nitric oxide synthase inhibitors have opposite effects on acute inflammation depending on their route of administration. J Immunol 166 (2001) 1169-1177
12. Chenevier-Gobeaux C., Morin-Robinet S., Lemarechal H., Poiraudeau S., Ekindjian J.C., and Borderie D. Effects of pro- and anti-inflammatory cytokines and nitric oxide donors on hyaluronic acid synthesis by synovial cells from patients with rheumatoid arthritis. Clin Sci 107 (2004) 291-296
13. Fletcher D.S., Widmer W.R., Luell S., Christen A., Orevillo C., Shah S., et al. Therapeutic administration of a selective inhibitor of nitric oxide synthase does not ameliorate the chronic inflammation and tissue damage associated with adjuvant-induced arthritis in rats. J Pharmacol Exp Ther 284 (1998) 714-721
14. Jang D., and Murrell G.A. Nitric oxide in arthritis. Free Radic Biol Med 24 (1998) 1511-1519
15. Miletie T., Kovacevie V., ujie V., Stanojevic S., Mitie K., Lazarevic Macanovic M., et al. Reactive oxygen species (ROS), but not nitric oxide (NO), contribute to strain differences in the susceptibility to experimental arthritis in rats. Immunobiology 212 (2007) 95-105
16. Weinberg J.B., Fermor B., and Guilak F. Nitric oxide synthase and cyclooxygenase interactions in cartilage and meniscus: relationships to joint physiology, arthritis, tissue repair. Subcell Biochem 42 (2007) 31-62
17. Hansel S., Lssig G., Pistrosch F., and Passauer J. Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity. Atherosclerosis 170 (2003) 177-180
18. Vaudo G., Marchesi S., and Gerli R. Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis 63 (2004) 31-35
19. Gunnett C.A., Lund D.D., McDowell A.K., Faraci F.M., and Heistad D.D. Mechanisms of inducible nitric oxide synthase-mediated vascular dysfunction. Arterioscler Thromb Vasc Biol 25 (2005) 1617-1622
20. Xu J., Xie Z., Reece R., Pimental D., and Zou M.H. Uncoupling of endothelial nitric oxide synthase by hypochlorus acid: role of NAD(P)H oxidase-derived superoxide and peroxynitrite. Arterioscler Thromb Vasc Biol 26 (2006) 2688-2695
21. Maki-Petaja K.M., Cheriyan J., Booth A.D., Hall F.C., Brown J., Wallace S.M.L., et al. Inducible nitric oxide synthase is increased in patients with rheumatoid arthritis and contributes to endothelial dysfunction. Int J Cardiol 129 (2008) 399-405
22. Hobbs A.J., Higgs A., and Moncada S. Inhibition of nitric oxide synthase as a potential therapeutic target. Annu Rev Pharmacol Toxicol 39 (1999) 191-220
23. Dimmeler S., Haendeler J., Nehls M., and Zeiher A. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (1CE)-like and cysteine protease protein (CPPP)-32-like proteases. J Exp Med 185 (1997) 601-607
24. Bogdan C. Nitric oxide and the immune response. Nat Immunol (2001) 907-916
25. Luoma J.S., Stralin P., Marklund S.L., Hiltunen T.P., Sarkioja T., and Yla-Hertluala S. Expression of SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Atheroscler Thromb Vasc Biol 18 (1998) 157-167
26. Arstall M.A., Sawyer D.M., Fukazawa R., and Kelly R.A. Cytokine-mediated apoptosis in cardiac myocytes: the role of inducible nitric oxide synthase induction and peroxynitrite generation. Circ Res 85 (1999) 829-840
27. Kwak H.J., Park K.M., Lee S., Lim H.J., Go S.H., Eom S.M., et al. Preconditioning with low concentration NO attenuates subsequent NO-induced apoptosis in vascular smooth muscle cells via HO-1-dependent mitochondrial death pathway. Toxicol Appl Pharmacol 217 (2006) 176-184
28. Trentham D.E., Townes A.S., and Kang A.H. Autoimmunity to type II collagen: an experimental model of arthritis. J Exp Med 146 (1977) 857-868
29. Wooley P.H., Luthra H.S., Stuart J.M., and David C.S. Type II collagen-induced arthritis in mice. Major histocompatibility complex (I region) linkage and antibody response. J Exp Med 154 (1981) 688-700
30. Philippe L., Pascale G.P., Corinne G., Karim B., Bernard T., Patrick N., et al. Relations between functional, inflammatory, and degenerative parameters during adjuvant arthritis in rats. Am J Physiol 273 (1997) R1550-R1556
31. Mary R.L., Geetha T., and Varalakshmi P. Effect of Vernonia cinerea less flower extract in adjuvant-induced arthritis. Gen Pharmaclol. 31 (1998) 601-606
32. David L.B., Elizabeth A.K., Michael F.J., Chih-Hung L., Shripad S.B., Michael W., et al. Anti-inflammatory effects of ABT-702, a novel non-nucleoside adenosine kinase inhibitor, in rat adjuvant arthritis. J Pharmacol Exp Ther 296 (2001) 495-500
33. Andersen M.L., and Tufik S. Altered sleep and behavioral patterns of arthritic rats. Sleep Res Online 3 (2000) 161-167
34. McCartney-Francis N.L., Chan J., and Wahl S.M. Inflammatory joint disease: clinical, histological, and molecular parameters of acute and chronic inflammation and tissue destruction. In: Winyard P.G., and Willoughby D.A. (Eds). Inflammation protocols (2003), Humana Press, New Jersey 147-159 G.J. Dusting. Nitric oxide in coronary artery disease: roles in atherosclerosis, myocardial
35. Watnich A.S. The adjuvant arthritic rat: a tool for discovering antiarthritic drugs. In: Rosenthale M.E., and Mansmann Jr. H. (Eds). Immunopharmacology (1975), Spectrum, New York 90-105
36. Santos L., and Tipping P.G. Attenuation of adjuvant arthritis in rats by treatment with oxygen radical scavengers. Immunol Cell Biol 72 (1994) 747-749
37. Cake M.A., Appleyard R.C., Read R.A., Ghosh P., Swain M.V., and Murrell G.C. Topical administration of the nitric oxide donor glyceryl trinitrate modifies the structural and biomechanical properties of ovine articular cartilage. Osteoarthr Cartil 11 (2003) 872-878
38. Cake M.A., Read R.A., Appleyard R.C., Hwa S.Y., and Ghosh P. The nitric oxide donor glyceryl trinitrate increases subchondral bone sclerosis and cartilage degeneration following ovine meniscectomy. Osteoarthr Cartil 12 (2004) 974-981
39. Kim H.A., Lee K.B., and Bae S.C. The mechanism of low-concentration sodium nitroprusside-mediated protection of chondrocyte death. Arthritis Res Therapy 7 (2005) R 526-R 535
40. Del Carlo M., and Loeser R.F. Nitric oxide-mediated chondrocyte cell death requires the generation of additional reactive oxygen species. Arthritis Rheum 46 (2002) 394-403
41. Del Carlo M., and loeser R.F. Increased oxidative stress with aging reduces chondrocyte survival: correlation with intracellular glutathione levels. Arthritis Rheum 48 (2003) 3419-3430
42. Afonso V., Champy R., Mitrovic D., Collin P., and Lomri A. Reactive oxygen species and superoxide dismutases: role in joint diseases. Jt Bone Spine 74 (2007) 324-329
43. Belgolovykh L.A., Dubikov A.I., and Medved E.E. Nitroxide synthase activities at different stages of adjuvant arthritis. Bull Exp Biol Med 143 5 (2007) 638-641
44. Laitao R.F., Rocha F.A., Chaves H.V., Lima V., Cunha F.Q., Ribeiro R.A., et al. Locally applied isosorbide decreases bone resorption in experimental periodontitis in rats. J Periodontol 75 (2004) 1227-1232
45. Huang L., Qui N., Zhang C., Wei H.Y., Li Y.L., Zhou H.H., et al. Nitroglycerin enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via nitric oxide pathway. Acta Pharmacol Sin 29 (2008) 580-586
46. Whiteman M., Rose P., Siau J.L., and Halliwell B. Nitrite-mediated protection against hypochlorous acid-induced chondrocyte toxicity: a novel cytoprotective role of nitric oxide in the inflamed joint?. Arthritis Rheum 48 (2003) 3140-3150
47. Prado W.A., Schiavon V.F., and Cunha F.Q. Dual effect of local application of nitric oxide donors in a model of incision pain in rats. Eur J Pharmacol 441 (2002) 57-65
48. Rocha J.C.S., Peixoto M.E.B., Jancer S., Cunha F.Q., Ribeiro R.A., and Rocha F.A.C. Dual effect of nitric oxide in articular inflammatory pain in zymosan-induced arthritis in rats. Br J Pharmacol 136 (2002) 588-596
49. Berrazueta J.R., Losada A., Poveda J., Ochoteco A., Riestra A., Salas E., et al. Successful treatment of shoulder pain syndrome due to supraspinatus tendonitis with transdermal nitroglycerin. A double blind study. Pain 66 (1995) 63-67
50. Duarte I.D.G., Lorenzetti B.B., and Ferreira S.H. Peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Eur J Pharmacol 186 (1990) 289-293
51. Calvino B., Crepon-Bernard M.A., and Le Bars D. Parallel clinical and behavioral studies of adjuvant-induced arthritis in the rat: possible relationship with "chronic pain". Behav Brain Res 24 (1987) 11-29
52. Dardick S.J., Basbaum A.I., and Levine J.D. The contribution of pain to disability in experimentally induced arthritis. Arthritis Rheum 29 (1989) 1017-1022
53. Koufany M., Moulin D., Bianchi A., Muresan M., Sebillaud S., Netter P., et al. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis. Arthritis Res Therapy 10 (2008) R6-15
54. Fiorentino D.F., Zlotinik A., Mosmann T.R., Howard M., and O'Garra A. Interleukin-10 inhibits cytokine production by activated macrophages. J Immunol 147 (1991) 3815-3822
55. Hancock C.M., and Riegger-Krugh C. Modulation of pain in osteoarthritis: role of nitric oxide. Clin J Pain 24 (2008) 353-365
56. Chang K., Lee S.J., Cheong I., Billiar T.R., Chung H.T., Han J.A., et al. Nitric oxide suppresses inducible nitric oxide synthase expression by inhibiting post-translation modification of 1KappaB. Exp Mol Med 36 (2004) 311-324